CX-659S

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCX-659S
Drug Alias NameCX-659S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis, ContactDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Energy Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJapan Energy Corp
Active IndicationsN/A
Inactive IndicationsDermatitis, ContactDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A